Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | UK Health Security Agency |
| Main Category: | Goods |
| Procurement Method: | Call-off from a framework agreement |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £456,000 |
| Release Date: | 13 March 2023 |
| Application Deadline: | 20 February 2023 |
| Contract Start Date: | 21 February 2023 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £456,000 |
| Award decision date: | 21 February 2023 |
| Award status: | Active |
Call-off from the RE18339: UK Shared Business Services Molecular Biology & Laboratory Chemicals (Lot 3) framework for the provision of USFDA Approved Cell Growth Medium.
Published contracts in the last 12 months
289
total contracts
£440.3m
total value
£1,719,777
average contract size
Typical categories
Request for Information - Lyophilisation services
UK Health Security Agency · WAC-618288
Request for Information - Lyophilisation services
UK Health Security Agency · WAC-618289
Request for Information - Oligonucleotides Onshoring
UK Health Security Agency · WAC-611114
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
20 February 2023
Closed
Estimated Value
£456,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 20 February 2024 |
| Contract Duration: | 1.0 years |
| Procurement ID (OCID): | ocds-b5fd17-a660b212-9e34-48ae-9e8a-8822120b25b6 |
| Notice Reference: | be83f933-f1eb-4656-9539-10e0f0d6f620-623411 |